CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress ...Middle East

News by : (PR Newswire) -
SEATTLE, June 10, 2022 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced two scientific poster presentations from the Company's pacritinib clinical program at the European Hematology Association (EHA) 2022 Congress, being held in Vienna, Austria, June 9-12, 2022. "Our...

Hence then, the article about cti biopharma presents pivotal data from pacritinib program at the european hematology association eha 2022 congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار